Schedule 13G ownership disclosure
Delmar Pharmaceuticals Inc
Security class unavailable · CUSIP: 247078207
Event date: 2017-09-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-17-010100
- Form type
- SC 13G
- Filer
- TuHURA Biosciences, Inc./NV
- CIK
- CIK 1498382
- Filed
- Sep 28, 2017
- Reporting period
- Sep 20, 2017
- Description
- Schedule 13G beneficial ownership